CNS Pharmaceuticals, Inc. Quarterly Current Ratio in % from Q2 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
CNS Pharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q2 2020 to Q2 2024.
  • CNS Pharmaceuticals, Inc. Current Ratio for the quarter ending June 30, 2024 was 32.1 %, a 86.8% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 32.1 -211 -86.8% Jun 30, 2024
Q1 2024 55.8 -304 -84.5% Mar 31, 2024
Q4 2023 92.1 -489 -84.1% Dec 31, 2023
Q3 2023 164 -562 -77.4% Sep 30, 2023
Q2 2023 244 -396 -61.9% Jun 30, 2023
Q1 2023 360 -238 -39.8% Mar 31, 2023
Q4 2022 581 +62.3 +12% Dec 31, 2022
Q3 2022 726 +62.7 +9.47% Sep 30, 2022
Q2 2022 640 -86.7 -11.9% Jun 30, 2022
Q1 2022 598 -161 -21.2% Mar 31, 2022
Q4 2021 519 -416 -44.5% Dec 31, 2021
Q3 2021 663 -786 -54.2% Sep 30, 2021
Q2 2021 727 -116 -13.7% Jun 30, 2021
Q1 2021 759 Mar 31, 2021
Q4 2020 934 Dec 31, 2020
Q3 2020 1.45K Sep 30, 2020
Q2 2020 843 Jun 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.